Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Barker

Showing results (381-390 of 419) with videos related to

Pageof 42
Sort By:
Neurosurgery|December 18, 2010
Comparative effectiveness of ventral vs dorsal surgery for cervical spondylotic myelopathyZoher Ghogawala, Brook Martin, Edward C Benzel, et al.
Neurology|November 20, 2013
Recommendations for imaging tumor response in neurofibromatosis clinical trialsEva Dombi, Simone L Ardern-Holmes, Dusica Babovic-Vuksanovic, et al.
World Neurosurgery|October 13, 2019
Atypical Histopathological Features and the Risk of Treatment Failure in Nonmalignant Meningiomas: A Multi-Institutional AnalysisNayan Lamba, William L Hwang, Daniel W Kim, et al.
Neurosurgery|November 28, 2018
A Clinical Rule for Preoperative Prediction of BRAF Mutation Status in CraniopharyngiomasShingo Fujio, Tareq A Juratli, Kazunori Arita, et al.
Neurosurgery|June 24, 2024
Patients May Return to Work Sooner After Laminoplasty: Occupational Outcomes of the Cervical Spondylotic Myelopathy Surgical TrialStephen P Miranda, Robert G Whitmore, Adam Kanter, et al.
Journal of the National Cancer Institute|October 27, 2015
Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted TherapyPriscilla K Brastianos, Ganesh M Shankar, Corey M Gill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastomaChristopher E Pelloski, Karla V Ballman, Alfred F Furth, et al.
The Lancet. Oncology|July 9, 2017
Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trialPaul D Brown, Karla V Ballman, Jane H Cerhan, et al.
Journal of Neurological Surgery. Part B, Skull Base|November 22, 2019
Genomic Analysis of Posterior Fossa Meningioma Demonstrates Frequent <i>AKT1 E17K</i> Mutations in Foramen Magnum MeningiomasSally R Williams, Tareq A Juratli, Brandyn A Castro, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|January 25, 2021
Working Toward Consensus on Sporadic Vestibular Schwannoma Care: A Modified Delphi StudyMatthew L Carlson, Michael J Link, Colin L W Driscoll, et al.
Pageof 42

Showing results (381-390 of 419) with videos related to

Sort By:
Pageof 42
Neurosurgery|December 18, 2010
Comparative effectiveness of ventral vs dorsal surgery for cervical spondylotic myelopathyZoher Ghogawala, Brook Martin, Edward C Benzel, et al.
Neurology|November 20, 2013
Recommendations for imaging tumor response in neurofibromatosis clinical trialsEva Dombi, Simone L Ardern-Holmes, Dusica Babovic-Vuksanovic, et al.
World Neurosurgery|October 13, 2019
Atypical Histopathological Features and the Risk of Treatment Failure in Nonmalignant Meningiomas: A Multi-Institutional AnalysisNayan Lamba, William L Hwang, Daniel W Kim, et al.
Neurosurgery|November 28, 2018
A Clinical Rule for Preoperative Prediction of BRAF Mutation Status in CraniopharyngiomasShingo Fujio, Tareq A Juratli, Kazunori Arita, et al.
Neurosurgery|June 24, 2024
Patients May Return to Work Sooner After Laminoplasty: Occupational Outcomes of the Cervical Spondylotic Myelopathy Surgical TrialStephen P Miranda, Robert G Whitmore, Adam Kanter, et al.
Journal of the National Cancer Institute|October 27, 2015
Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted TherapyPriscilla K Brastianos, Ganesh M Shankar, Corey M Gill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2007
Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastomaChristopher E Pelloski, Karla V Ballman, Alfred F Furth, et al.
The Lancet. Oncology|July 9, 2017
Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trialPaul D Brown, Karla V Ballman, Jane H Cerhan, et al.
Journal of Neurological Surgery. Part B, Skull Base|November 22, 2019
Genomic Analysis of Posterior Fossa Meningioma Demonstrates Frequent <i>AKT1 E17K</i> Mutations in Foramen Magnum MeningiomasSally R Williams, Tareq A Juratli, Brandyn A Castro, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|January 25, 2021
Working Toward Consensus on Sporadic Vestibular Schwannoma Care: A Modified Delphi StudyMatthew L Carlson, Michael J Link, Colin L W Driscoll, et al.
Pageof 42